The Role of Medical Affairs in Pharma Explained

Medical affairs acts as the scientific bridge between pharmaceutical companies and healthcare professionals. When a new therapy launches, a medical science liaison meets with a specialist to understand how it's being used in real-world practice. This feedback is important because it can help shape future research.

Without a connected way to capture and share that feedback with clinical, commercial, regulatory, and field medical teams, valuable insights can get lost, messaging can become inconsistent, and compliance risks can rise.

That’s where medical affairs plays a critical role, ensuring that scientific information is accurate, connected, and actionable across the organization.

Medical affairs in pharma is a core function within pharmaceutical and life sciences organizations that serves as a scientific bridge between research and development (R&D), commercial teams, and healthcare professionals. Its primary role is to ensure that medical and scientific information, such as clinical trial results and real-world evidence, is communicated with accuracy, compliance, and objectivity.

In practice, medical affairs ensures that scientific information supports effective clinical decision-making by helping ensure that therapies are understood and used appropriately in clinical practice. It translates complex data into clear, evidence-based insights that healthcare providers and other stakeholders can apply in real-world settings.

To support this role, medical affairs teams engage in a range of activities, including scientific exchange with healthcare professionals, medical education, and evidence generation. Field-based teams, such as medical science liaisons (MSLs), play a key role in sharing information and gathering insights, while internal teams ensure that communications remain consistent, accurate, and aligned with regulatory standards.

Medical affairs matters in life sciences because it ensures accurate, evidence-based communication and helps connect scientific insights to real-world patient care. It plays a significant role in supporting the work of a wide range of stakeholders to optimize patient outcomes in these ways:

As the scientific backbone of life sciences companies, medical affairs builds trust by ensuring unbiased, evidence-based exchange with key stakeholders. They also work to ensure compliance with FDA and other guidelines to prevent penalties, maintain trust, and guarantee patient safety.

To ensure that products meet patient needs, gain payer reimbursement, and improve patient outcomes, medical affairs professionals prioritize real-world evidence, clinical trial insights, and engagement with key opinion leaders.

By ensuring evidence-based, compliant communication, medical affairs staff maintain key connections between internal life sciences teams and external stakeholders. They translate data into strategy, allowing them to close the gap between clinical trial data and real-world clinical practice.

Medical affairs interprets trial data to demonstrate its clinical relevance to healthcare providers, enabling targeted medical strategies, optimizing physician engagement, accelerating label expansion, and improving patient outcomes.

As medical affairs becomes more strategic, many organizations are choosing connected platforms that unify data across clinical, medical, and commercial teams. Solutions like Agentforce 360 for Life Sciences help teams break down silos to enable more consistent communication and better-informed decision-making.

Medical affairs responsibilities include scientific exchange, medical education, evidence generation, and the collection of insights from healthcare professionals:

• Scientific exchange with healthcare professionals: It is important for medical affairs teams that engage with healthcare professionals to share clinical data and gather insights. They share those insights with research and development (R&D), marketing, and other departments across the organization. Platforms like Agentforce for Life Sciences enable teams to capture and connect these insights in real time to ensure more coordinated scientific engagement.
• Medical education and training: Medical affairs helps enhance understanding of treatments and disease states among key stakeholder groups by developing educational programs, engaging in scientific exchange with key opinion leaders, and training internal teams.
• Evidence generation and real-world data analysis: Medical affairs has taken on a strategic role by using real-world data and evidence generation to fill gaps in traditional clinical trials. Evidence generation requires analysis of data from multiple sources, which relies on modern platforms that can integrate structured and unstructured data across systems to enable teams to turn insights into actionable knowledge.
• Insights collection from healthcare stakeholders: Gathering. Insights from healthcare professionals are a key function in validating clinical strategies and guiding product development. Adopting AI agents like Agentforce for Life Science can help solve critical bottlenecks in field engagement by enabling the automation of insight capture and connecting internal and external data sources for a 360-degree view.

Medical affairs teams are responsible for ensuring that scientific and medical information is communicated accurately and compliantly, while capturing and applying insights from healthcare professionals to inform strategy, research, and patient care.

As the strategic bridge between scientific evidence and product commercialization at life sciences organizations, medical affairs must work closely with commercial, clinical, and regulatory teams.

While the focus for commercial teams is on promotion and sales, medical affairs teams center on scientific exchange rather than product promotion.

Clinical development teams are responsible for designing and running trials to generate data, while the role of medical affairs is to translate and support the use of evidence gathered during trials in practice.

Regulatory teams focus on securing approvals and ensuring materials — including drug labels, prescribing information, and promotional claims — meet legal requirements. Medical affairs, on the other hand, ensures that scientific information is communicated accurately and appropriately in practice.

All of these functions must work in tandem, with medical affairs playing a central role in aligning teams around accurate, evidence-based information.

The role of medical affairs in pharma continues to evolve, becoming more strategic and data-driven. This will be important as today’s life sciences organizations manage growing volumes of scientific information and engage healthcare professionals in more meaningful ways. With this shift, there will be a greater need for more collaboration across clinical, commercial, and medical functions.

To keep pace with this changing landscape, many organizations are looking to connected, intelligent platforms like Agentforce 360 for Pharma to help them unify data, streamline workflows, and support more effective scientific engagement with healthcare professionals.